Qrono Inc.

Description

• Qrono is a specialty pharmaceutical company that reformulates known, approved drugs and creates long-acting injectable (LAI) medications with improved clinical and economic benefits for patients and other healthcare stakeholders. These long-acting, patentable drug formulations enable a single administration of active pharmaceutical ingredient (API) to provide a therapeutic effect ranging from several days to many weeks or months. Our pipeline strategy focuses on drugs with known safety and efficacy profiles in therapeutic areas with either high non-adherence, or where LAIs can add therapeutic value. We further focus on off-patent medications to take advantage of the accelerated 505(b)(2) FDA regulatory pathway.Qrono develops LAI formulations significantly faster and with less regulatory risk than current practice by using our proprietary, first-of-a-kind predictive modeling technology, called QronoMetrics. We have demonstrated the ability to optimize formulation designs faster (~95%) , better (reduced initial burst, reduced regulatory risk, reduced production risk) and cheaper (>$1MM savings) than current best practice.Qrono also strategically offers long-acting formulation design services to other pharmaceutical companies.
• 

  Headquarters:4551 Forbes Avenue Suite 301, Pittsburgh, Pennsylvania, United States

  More
• 

  Phone Number: +1 412-213-8788

• 

  Website: https://www.qrono.com

• 

  Employees:4

• 

  Revenue:$1 - 10M

• 

  Legal Name:Qrono Inc.

• Qrono Inc.'s Social Media

  
• Is this data correct?

• |  NAICS Code: 541715  |

  Show More